Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis

OBJECTIVE: The JAK2V617F mutation is present in the majority of patients with essential thrombocythemia (ET) and primary myelofibrosis (PMF). The impact of this mutation on disease phenotype in ET and PMF is still a matter of discussion. This study aims to determine whether there are differences in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yönal, İpek, Dağlar-Aday, Aynur, Akadam-Teker, Başak, Yılmaz, Ceylan, Nalçacı, Meliha, Yavuz, Akif Selim, Sargın, Fatma Deniz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100738/
https://www.ncbi.nlm.nih.gov/pubmed/25913509
http://dx.doi.org/10.4274/tjh.2014.0136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100738/
https://www.ncbi.nlm.nih.gov/pubmed/25913509
http://dx.doi.org/10.4274/tjh.2014.0136

Ejemplares similares